Compare BSBK & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSBK | STIM |
|---|---|---|
| Founded | 1893 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.0M | 88.4M |
| IPO Year | 2019 | 2018 |
| Metric | BSBK | STIM |
|---|---|---|
| Price | $9.06 | $1.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 8.8K | ★ 1.3M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 200.00 | 57.25 |
| EPS | ★ 0.06 | N/A |
| Revenue | N/A | ★ $52,776,000.00 |
| Revenue This Year | N/A | $11.10 |
| Revenue Next Year | N/A | $11.92 |
| P/E Ratio | $151.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.90 | $0.80 |
| 52 Week High | $9.49 | $4.84 |
| Indicator | BSBK | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 57.00 | 55.17 |
| Support Level | $8.83 | $1.21 |
| Resistance Level | $9.29 | $1.42 |
| Average True Range (ATR) | 0.12 | 0.11 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 62.50 | 61.54 |
Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from, customers in New Jersey. The Company operates one reportable segment of business, retail banking. Through its community banking segment, the Company provides a broad range of retail and commercial banking services.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.